{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Shock+Lung&page=12", "query": { "condition": "Shock Lung", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 490, "total_pages": 49, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Shock+Lung&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Shock+Lung&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-24T06:45:57.365Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00113685", "title": "Hypertonic Saline With Dextran for Treating Hypovolemic Shock and Severe Brain Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Respiratory Distress Syndrome, Adult", "Head Injuries, Closed", "Shock", "Shock, Traumatic" ], "interventions": [ { "name": "Hypertonic Saline-Dextran Solution", "type": "DRUG" }, { "name": "Lactated Ringer's Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 209, "start_date": "2003-04", "completion_date": "2007-03", "has_results": false, "last_update_posted_date": "2021-05-03", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00113685" }, { "nct_id": "NCT02452476", "title": "A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Respiratory Distress Syndrome, Newborn" ], "interventions": [ { "name": "CHF5633", "type": "DRUG" }, { "name": "Poractant alfa", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Hour", "maximum_age": "24 Hours", "sex": "ALL", "summary": "1 Hour to 24 Hours" }, "enrollment_count": 123, "start_date": "2016-01-21", "completion_date": "2018-05-24", "has_results": true, "last_update_posted_date": "2021-08-13", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 23, "location_summary": "Mobile, Alabama • Los Angeles, California • Orange, California + 20 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Hartford", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT02452476" }, { "nct_id": "NCT01474863", "title": "Citrulline in Severe Sepsis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Severe Sepsis", "Acute Lung Injury" ], "interventions": [ { "name": "High Dose Citrulline", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Low Dose Citrulline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 72, "start_date": "2012-08", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2017-06-05", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01474863" }, { "nct_id": "NCT01461889", "title": "INR-Triggered Transfusion In GI Bleeders From ER", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Distress Syndrome, Adult", "Gastrointestinal Hemorrhage", "Liver Diseases", "Transfusion Related Lung Injury" ], "interventions": [ { "name": "Transfuse plasma to High INR target", "type": "OTHER" }, { "name": "Transfuse plasma to Low INR target", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Colorado, Denver", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 50, "start_date": "2011-07", "completion_date": "2015-08", "has_results": false, "last_update_posted_date": "2017-03-27", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 2, "location_summary": "Aurora, Colorado • Denver, Colorado", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01461889" }, { "nct_id": "NCT01541514", "title": "Evaluating the Patient-Ventilator Synchrony During Mechanical Ventilation in Patients With Acute Lung Injury", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Mechanically Ventilated ICU Patients" ], "interventions": [], "intervention_types": [], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2011-07", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-12-03", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01541514" }, { "nct_id": "NCT00569530", "title": "Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Distress Syndrome of Prematurity (Surfactant Dysfunction)", "Bronchopulmonary Dysplasia" ], "interventions": [ { "name": "Infasurf (ONY Inc.)", "type": "DRUG" }, { "name": "Sham", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Roberta Ballard", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "14 Days", "sex": "ALL", "summary": "7 Days to 14 Days" }, "enrollment_count": 85, "start_date": "2008-01", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2021-05-11", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 9, "location_summary": "Berkeley, California • Oakland, California • San Francisco, California + 5 more", "locations": [ { "city": "Berkeley", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00569530" }, { "nct_id": "NCT07656259", "title": "COMPARE-VENT Feasibility Pilot Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Respiration Failure", "Cardio Vascular Disease", "Cardiogenic Pulmonary Oedema", "Critical Illness", "Mechanical Ventilation", "Cardiogenic Shock", "Cardiopulmonary" ], "interventions": [ { "name": "Volume Controlled Mode", "type": "OTHER" }, { "name": "Pressure Controlled Mode", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 75, "start_date": "2026-07-01", "completion_date": "2027-06-30", "has_results": false, "last_update_posted_date": "2026-08-10", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07656259" }, { "nct_id": "NCT04540120", "title": "Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Covid19", "Cytokine Release Syndrome" ], "interventions": [ { "name": "dapansutrile capsules", "type": "DRUG" }, { "name": "placebo capsules", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Olatec Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 49, "start_date": "2020-09-24", "completion_date": "2022-07-28", "has_results": false, "last_update_posted_date": "2023-04-13", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 9, "location_summary": "Coral Gables, Florida • Fort Lauderdale, Florida • Hialeah, Florida + 6 more", "locations": [ { "city": "Coral Gables", "state": "Florida" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Hialeah", "state": "Florida" }, { "city": "Sunrise", "state": "Florida" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT04540120" }, { "nct_id": "NCT04064684", "title": "Inhaled Steroids for the Treatment of Early Pediatric Acute Respiratory Distress Syndrome", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acute Respiratory Distress Syndrome" ], "interventions": [ { "name": "Budesonide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Nebulizer", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Days", "maximum_age": "18 Years", "sex": "ALL", "summary": "30 Days to 18 Years" }, "enrollment_count": 2, "start_date": "2020-02-04", "completion_date": "2020-03-30", "has_results": true, "last_update_posted_date": "2022-07-13", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04064684" }, { "nct_id": "NCT07613099", "title": "Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Allogeneic Stem Cell Transplantation", "Lung Allograft Transplantation", "Interstitial Lung Disease", "Acute Lung Injury", "Pulmonary Arterial Hypertension", "Cardiovascular Diseases" ], "interventions": [ { "name": "[18F]FAPI-74", "type": "DRUG" }, { "name": "18F-FAPI-74 PET/CT Imaging", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "National Heart, Lung, and Blood Institute (NHLBI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "18 Years to 100 Years" }, "enrollment_count": 210, "start_date": "2026-09-18", "completion_date": "2033-05-26", "has_results": false, "last_update_posted_date": "2026-10-06", "last_synced_at": "2026-10-24T06:45:57.365Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07613099" } ] }